110 related articles for article (PubMed ID: 37942626)
21. Acid-activatable prodrug nanogels for efficient intracellular doxorubicin release.
Zhan F; Chen W; Wang Z; Lu W; Cheng R; Deng C; Meng F; Liu H; Zhong Z
Biomacromolecules; 2011 Oct; 12(10):3612-20. PubMed ID: 21905663
[TBL] [Abstract][Full Text] [Related]
22. Secretory phospholipase A2 as a tumor-specific trigger for targeted delivery of a novel class of liposomal prodrug anticancer etherlipids.
Jensen SS; Andresen TL; Davidsen J; Høyrup P; Shnyder SD; Bibby MC; Gill JH; Jørgensen K
Mol Cancer Ther; 2004 Nov; 3(11):1451-8. PubMed ID: 15542784
[TBL] [Abstract][Full Text] [Related]
23. A Dual Stimuli-Responsive Nanoplatform Loaded Pt
Fang K; Sun Y; Yang J; Hu X; Chen M; Li R; Yang X; Fan T; Wu J; Tong X; Dong C; Shi S
Adv Healthc Mater; 2023 Nov; 12(28):e2301328. PubMed ID: 37392128
[TBL] [Abstract][Full Text] [Related]
24. Dynamic core crosslinked camptothecin prodrug micelles with reduction sensitivity and boronic acid-mediated enhanced endocytosis: An intelligent tumor-targeted delivery nanoplatform.
Huang Y; Zhang W; Xu Y; Zhu S; Wu Y; Chen T; Xiao Y; Lu W; Zhang X; Yu J
Int J Pharm; 2020 Apr; 580():119250. PubMed ID: 32209369
[TBL] [Abstract][Full Text] [Related]
25. A light-controllable specific drug delivery nanoplatform for targeted bimodal imaging-guided photothermal/chemo synergistic cancer therapy.
Guo Y; Wang XY; Chen YL; Liu FQ; Tan MX; Ao M; Yu JH; Ran HT; Wang ZX
Acta Biomater; 2018 Oct; 80():308-326. PubMed ID: 30240955
[TBL] [Abstract][Full Text] [Related]
26. An albumin-binding dimeric prodrug nanoparticle with long blood circulation and light-triggered drug release for chemo-photodynamic combination therapy against hypoxia-induced metastasis of lung cancer.
Luo R; Zhang Z; Han L; Xue Z; Zhang K; Liu F; Feng F; Xue J; Liu W; Qu W
Biomater Sci; 2021 May; 9(10):3718-3736. PubMed ID: 34008617
[TBL] [Abstract][Full Text] [Related]
27. Tumor microenvironment-activated therapeutic peptide-conjugated prodrug nanoparticles for enhanced tumor penetration and local T cell activation in the tumor microenvironment.
Zhu X; Li C; Lu Y; Liu Y; Wan D; Zhu D; Pan J; Ma G
Acta Biomater; 2021 Jan; 119():337-348. PubMed ID: 33166712
[TBL] [Abstract][Full Text] [Related]
28. A prodrug hydrogel with tumor microenvironment and near-infrared light dual-responsive action for synergistic cancer immunotherapy.
Ding M; Fan Y; Lv Y; Liu J; Yu N; Kong D; Sun H; Li J
Acta Biomater; 2022 Sep; 149():334-346. PubMed ID: 35779775
[TBL] [Abstract][Full Text] [Related]
29. Encapsulation of doxorubicin prodrug in heat-triggered liposomes overcomes off-target activation for advanced prostate cancer therapy.
Pereira S; Ma G; Na L; Hudoklin S; Kreft ME; Kostevsek N; Al-Jamal WT
Acta Biomater; 2022 Mar; 140():530-546. PubMed ID: 34954416
[TBL] [Abstract][Full Text] [Related]
30. Multi-Site Attack, Neutrophil Membrane-Camouflaged Nanomedicine with High Drug Loading for Enhanced Cancer Therapy and Metastasis Inhibition.
Huang R; Fan D; Cheng H; Huo J; Wang S; He H; Zhang G
Int J Nanomedicine; 2023; 18():3359-3375. PubMed ID: 37361388
[TBL] [Abstract][Full Text] [Related]
31. Noninvasive theranostic imaging of HSV1-sr39TK-NTR/GCV-CB1954 dual-prodrug therapy in metastatic lung lesions of MDA-MB-231 triple negative breast cancer in mice.
Sekar TV; Foygel K; Ilovich O; Paulmurugan R
Theranostics; 2014; 4(5):460-74. PubMed ID: 24669276
[TBL] [Abstract][Full Text] [Related]
32. Programmable therapeutic nanoscale covalent organic framework for photodynamic therapy and hypoxia-activated cascade chemotherapy.
He H; Du L; Xue H; Wu J; Shuai X
Acta Biomater; 2022 Sep; 149():297-306. PubMed ID: 35811069
[TBL] [Abstract][Full Text] [Related]
33. Stimuli-responsive polymeric prodrug-based nanomedicine delivering nifuroxazide and doxorubicin against primary breast cancer and pulmonary metastasis.
Luo L; Xu F; Peng H; Luo Y; Tian X; Battaglia G; Zhang H; Gong Q; Gu Z; Luo K
J Control Release; 2020 Feb; 318():124-135. PubMed ID: 31838206
[TBL] [Abstract][Full Text] [Related]
34. Ocular drug metabolism of the bioactivating antioxidant N-acetylcarnosine for vision in ophthalmic prodrug and codrug design and delivery.
Babizhayev MA
Drug Dev Ind Pharm; 2008 Oct; 34(10):1071-89. PubMed ID: 18777243
[TBL] [Abstract][Full Text] [Related]
35. [Liposome formulations of combretastatin A4 and 4-arylcoumarin analog prodrugs: antitumor effect in the mouse model of breast cancer].
Mouseeva EV; Kuznetsova NR; Svirshchevskaia EV; Bovin NV; Sitnikov NC; Shavyrin AS; Beletskaia IP; Combes S; Fedorov AIu; Vodovozova EL
Biomed Khim; 2012; 58(3):326-38. PubMed ID: 22856138
[TBL] [Abstract][Full Text] [Related]
36. A ROS-Responsive Simvastatin Nano-Prodrug and its Fibronectin-Targeted Co-Delivery System for Atherosclerosis Treatment.
Zhao R; Ning X; Wang M; Wang H; Xing G; Wang L; Lu C; Yu A; Wang Y
ACS Appl Mater Interfaces; 2022 Jun; 14(22):25080-25092. PubMed ID: 35618653
[TBL] [Abstract][Full Text] [Related]
37. Hyaluronic acid-shelled acid-activatable paclitaxel prodrug micelles effectively target and treat CD44-overexpressing human breast tumor xenografts in vivo.
Zhong Y; Goltsche K; Cheng L; Xie F; Meng F; Deng C; Zhong Z; Haag R
Biomaterials; 2016 Apr; 84():250-261. PubMed ID: 26851390
[TBL] [Abstract][Full Text] [Related]
38. Low density lipoprotein-inspired nanostructured lipid nanoparticles containing pro-doxorubicin to enhance tumor-targeted therapeutic efficiency.
Li W; Fu J; Ding Y; Liu D; Jia N; Chen D; Hu H
Acta Biomater; 2019 Sep; 96():456-467. PubMed ID: 31260821
[TBL] [Abstract][Full Text] [Related]
39. ROS-triggered cycle amplification effect: A prodrug activation nanoamplifier for tumor-specific therapy.
Huang Z; Ding Y; Luo Y; Chen M; Zeng Z; Zhang T; Sun Y; Huang Y; Zhao C
Acta Biomater; 2022 Oct; 152():367-379. PubMed ID: 36084924
[TBL] [Abstract][Full Text] [Related]
40. TIMP-2 mediates the anti-invasive effects of the nitric oxide-releasing prodrug JS-K in breast cancer cells.
Simeone AM; McMurtry V; Nieves-Alicea R; Saavedra JE; Keefer LK; Johnson MM; Tari AM
Breast Cancer Res; 2008; 10(3):R44. PubMed ID: 18474097
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
